Cytokines and skeletal physiology

Clinical Orthopaedics and Related Research

Volumn 324, Issue , 1996, Pages 13-23

  Goldring, Steven R ^a,b   Goldring, Mary B ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; CHEMOKINE; COLONY STIMULATING FACTOR; CYTOKINE; GROWTH FACTOR; INTERFERON; INTERLEUKIN DERIVATIVE; TUMOR NECROSIS FACTOR;

BONE GROWTH; BONE REMODELING; BONE TISSUE; CELL FUNCTION; CELL INTERACTION; CELL MATURATION; CELL POPULATION; CONFERENCE PAPER; HUMAN; HUMAN CELL; PHYSIOLOGY; PLEIOTROPY; PRIORITY JOURNAL;

EID: 0030030025     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-199603000-00003     Document Type: Conference Paper

References (67)

1. Anklesaria P, Teixido J, Laiho M: Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor α to epidermal growth factor receptors promotes cell proliferation. Proc Natl Acad Sci USA 87:3289-3293, 1990.
2. Arend WP, Dayer J-M: Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 33:305-315, 1990.
3. Arend WP, Dayer J-M: Naturally Occurring Inhibitors of Cytokines. In Davies ME, Dingle JT (eds). Immunopharmacology of Joints and Connective Tissue. London, Academic Press 129-149, 1994.
4. Arend WP, Dayer J-M: Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 38:151-160, 1995.
5. Arend WP, Welgus HG, Thompson RC, Eisenberg SP: Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J Clin Invest 85:1694-1697, 1990.
6. Baker J, Liu JP, Robertson EJ, Efstratiadis A: Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82, 1993.
7. Bazan JF: Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 87:6934-6938, 1990.
8. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR: Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 319:516-518, 1986.
9. Beutler B, Heuffel V: Unraveling function in the TNF ligand and receptor families. Science 264:667-668, 1994.
10. Canalis E, Centrella M, Burch W, McCarthy TL: Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. J Clin Invest 83:60-65, 1989.
11. Canalis E, Lian JB: Effects of bone associated growth factors on DNA, collagen and osteocalcin synthesis in cultured fetal rat calvariae. Bone 9:243-246, 1988.
12. Canalis E, McCarthy T, Centrella M: Growth factors and the regulation of bone remodeling. J Clin Invest 81:277-281, 1988.
13. Centrella M, McCarthy TL, Canalis E: Transforming growth factor β is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem 262:2869-2874, 1987.
14. 2 production by human synovial cells. J Clin Invest 77:645-648, 1986.
15. 2 and cyclic adenosine 3′,5′-monophosphate. Biochem Biophys Acta 586:87-105, 1979.
16. Dayer J-M, Seckinger P: Interleukin 1 and Interleukin 1 Inhibitors and Their Relation to Connective Tissue Destruction. In Glauert AM (ed). The Control of Tissue Damage. Vol 15. Amsterdam, Elsevier 151-163, 1988.
17. Dinarello CA: Cytokines: Interleukin-1 and Tumor Necrosis Factor (cachectin). In Gallin JI, Goldstein IM, Synderman R (eds). Inflammation: Basic Principles and Clinical Correlates. New York, Raven Press 195-221, 1988.
18. Elford PR, Guenther HL, Felix R, Cecchini MG, Fleisch H: Transforming growth factor-β reduces the phenotypic expression of osteoblastic MC3T3-E1 cells in monolayer culture. Bone 8:259-262, 1987.
19. Eriebacher A, Filvaroff EH, Gitelman SE, Derynck R: Toward a molecular understanding of skeletal development. Cell 80:371-378, 1995.
20. Felix R, Cecchini MG, Fleisch H: Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology 127:2592-2594, 1990.
21. Goldring MB, Birkhead J, Sandell LJ, Kimura T, Krane SM: Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. J Clin Invest 82:2026-2037, 1988.
22. Goldring MB, Birkhead J, Sandell LJ, Krane SM: Synergistic regulation of collagen gene expression in human chondrocytes by tumor necrosis factor-α and interleukin-β. Ann NY Acad Sci 580:536-539, 1990.
23. Goldring MB, Goldring SR: Skeletal tissue response to cytokines. Clin Orthop 78:245-278, 1990.
24. Goldring MB, Goldring SR: Cytokines and cell growth control. Crit Rev E Gene Expres 1:301-326, 1991.
25. Goldring SR, Flannery MS, Harris T, et al: Biological effects of interleukin 1 on human osteoblast-like cells are mediated by specific cell receptors. J Bone Miner Res 4:S257, 1989.
26. Goldring SR, Roelke MS, Petrison KK, Evins AE, Krane SM: Mechanisms by which monocytemacrophage products regulate responses of connective tissue (bone and synovial) cells to hormones. J Bone Miner Res 2:S239, 1987.
27. Guenther HL, Cecchini MG, Elford PR, Fleisch H: Effects of transforming growth factor type beta upon bone cell populations grown either in monolayer or semisolid medium. J Bone Miner Res 3:269-278, 1988.
28. Horowitz MC, Jilka RL: Colony Stimulating Factors and Bone Remodeling, Cytokines and Bone Metabolism. In Gowen M (ed). Boca Raton, FL, CRC Press 185-227, 1992.
29. Hunziker EB, Wagner J, Zapf J: Differential effects of insulin-like growth factor 1 and growth hormone on developmental stages of rat growth plate chondrocytes in vivo. J Clin Invest 93:1078-1086, 1994.
30. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11-25, 1992.
31. 2 on a mouse clonal osteoblastlike cell line MC3T3-E1. J Bone Miner Res 4:37-45, 1989.
32. Ihle JN, Witthuhn BA, Quell FW, et al: Signaling by cytokine receptor superfamily: JAKs and STATs. Trends Biol Sci 19:222-227, 1994.
33. Jilka RL, Hangoc G, Girasole G, et al: Increased osteoclast development after estrogen loss: Mediation by IL-6. Science 257:88-91, 1992.
34. Joyce ME, Roberts AB, Sporn MB, Bolander ME: Transforming growth factor-β and the initiation of chondrogenesis and osteogenesis in rat femur. J Cell Biol 110:2195-2207, 1990.
35. Kimble RB, Vannice JL, Bloedow DC, et al: Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. J Clin Invest 93:1959-1967, 1994.
36. Kingsley DM: What do BMPs do in mammals?: Clues from the mouse short-ear mutation. Trends Genet 10:16-21, 1994.
37. Kingsley DM, Bland AE, Grubber AM, et al: The mouse short ear skeletal morphogenesis locus is associated with defects in bone in a bone morphogenic member of the TGF-β superfamily. Cell 71:399-410, 1992.
38. Kishimoto T, Akira S, Taga T: Interleukin-6 and its receptor: A paradigm for cytokines. Science 258: 593-596, 1992.
39. Kishimoto T, Taga T, Akira S: Cytokine signal transduction. Cell 76:253-262, 1994.
40. Lewis DB, Liggitt HD, Effman EL, et al: Osteoporosis induced in mice by overproduction of interleukin 4. Proc Natl Acad Sci USA 90:11618-11622, 1993.
41. Lin HY, Lodish H: Receptors for the TGF-β superfamily: Multiple polypeptides and serine/threonine kinases. Trends Cell Biol 3:14-19, 1993.
42. Lorenzo JA, Sousa SL, Alander C, Raisz LG, Dinarello CA: Comparison of the bone-resorbing activity in the supernatants from phytohemagglutinin-stimulated human peripheral blood mononuclear cells with that of cytokines through the use of an antiserum to interleukin 1. Endocrinology 121:1164-1170, 1987.
43. Manolagas SC, Jilka RL: Bone marrow, cytokines, and bone remodeling: Emerging insights into the pathophysiology of osteoporosis. New Engl J Med 332:305-311, 1995.
44. Medhora MM, Teitelbaum S, Chappel J, et al: 1 alpha,25-dihydroxyvitamin D3 upregulates expression of the osteoclast integrin alpha V beta 3. J Biol Chem 268:1456-1461, 1993.
45. Miyajima A, Hara T, Kitamura T: Common subunits of cytokine receptors and the functional redundancy of cytokines. Trends Biol Sci 17:378-382, 1992.
46. Mundy GR: Role of cytokines in bone resorption. J Cell Biochem 53:296-300, 1993.
47. Nakase T, Nomura S, Yoshikawa H, et al: Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing. J Bone Miner Res 9:651-659, 1994.
48. Nathan C, Sporn M: Cytokines in context. J Cell Biol 113:981-986, 1991.
49. Neote K, DiGregorio D, Mak JY, Horuk R, Schall TJ: Molecular cloning, functional expression and signalling characteristics of a C-C chemokine receptor. Cell 72:415-125, 1993.
50. Oyajobi BO, Russell RGG: Bone Remodeling, Cytokines, and Joint Disease. In Keuttner K (ed). Articular Cartilage and Osteoarthritis. New York. Raven Press 333-349, 1993.
51. Pacifici R, Brown C, Puscheck E, et al: Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 88:5134-5138, 1991.
52. Pacifici R, Rifas L, McCracken R, et al: Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA 86:2398-2402, 1989.
53. Poli V, Balena R, Fattori E, et al: Interleukin-6 defi cient mice are protected from bone loss caused by estrogen depletion. EMBO J 13:1189-1196, 1994.
54. Raisz LG: Local and systemic factors in the pathogenesis of osteoporosis. N Engl J Med 318:818-828, 1988.
55. Rousseau F, Bonaventure J, Legeai-Mallet L, et al: Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371:252-254, 1994.
56. Sato N, Miyajima A: Multimeric cytokine receptors: Common versus specific functions. Cur Opin Cell Biol 6:174-179, 1994.
57. Schlessinger J, Ullrich A: Growth factor signalling by tyrosine kinases. Neuron 9:383-391, 1992.
58. Schmid C, Ernst E: Insulin-like Growth Factors. In Gowen M (ed). Cytokines and Bone Metabolism. Boca Raton, FL, CRC Press 229-265, 1992.
59. Schwartz MA, Ingber DE: Integrating with integrins. Mol Biol Cell 5:389-393, 1994.
60. Shiang R, Thompson LM, Zhu YZ, et al: Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78:335-342, 1994.
61. Suda T, Takahashi N, Martin TJ: Modulation of osteoclast differentiation. Endocr Rev 13:66-80, 1992.
62. Tashjian AH Jr, Voelkel EF, Lazzaro M, et al: Tumor necrosis factor-α (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism. Endocrinology 120:2029-2036, 1987.
63. Tashjian AH Jr, Voelkel EF, Lloyd W, et al: Actions of growth factors on plasma calcium. J Clin Invest 78:1405-1409, 1986.
64. Thomson BM, Mundy GR, Chambers TJ: Tumor necrosis factors α and β induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol 138:775-779, 1987.
65. Thomson BM, Saklatvala J, Chambers TJ: Osteoblasts mediate interleukin 1 responsiveness of bone resorption by rat osteoclasts. J Exp Med 104:104-112, 1986.
66. Wozney JM, Rosen V, Celeste AJ, et al: Novel regulators of bone formation: Molecular clones and activities. Science 242:1528-1534, 1988.
67. Yoshida H, Hayashi SI, Kunisada T, et al: The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345:442-444, 1990.